Friday, June 14, 2024

TransCode Therapeutics prices $8M offering

Must read

Sep. 26, 2023 3:21 AM ETTransCode Therapeutics, Inc. (RNAZ)By: Manshi Mamtora, CFA

  • TransCode Therapeutics (NASDAQ:RNAZ) priced its underwritten public offering of an aggregate of 15.7M shares and pre-funded warrants.
  • Each share of common stock is being sold at a public offering price of $0.51 per share .
  • Total gross proceeds are expected to be ~$8M.
  • Underwriters have a 45-day option to purchase up to ~2.34M additional shares and/or pre-funded warrants at the public offering price less the underwriting discount.
  • The closing of the offering is expected to occur on or about September 28, 2023.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

More articles

Latest article